Fig. 2: Cell subsets in PBMCs in 3 ESCC patients pre- and post-anti-PD-1 therapy.
From: Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer
A UMAP projection of PBMCs from 3 ESCC patients with pre- and post-treatment samples, colored by cell type. Each dot represents a cell. B Marker genes, population size and fraction of cells pre-and post-anti-PD-1 therapy for each cell type in PBMC from the 3 ESCC patients. C Population change index (PopIndex) of T-cell subsets (left panel) and B-cell subsets (right panel) in PBMCs from the 3 ESCC patients pre- and post-anti-PD-1 therapy.
